Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
Springer-Verlag New York Inc., 2011
244,95 €On orderDelivery: 2-3 weeks
The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents.
- ISBN-13
- 9781461288886
- ISBN-10
- 1461288886
- Publisher
- Springer-Verlag New York Inc.
- Year
- 2011
- Publication date
- 2011-10-10
- Pages
- 298
- Dimensions
- 154x234x23
- Weight
- 490